An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, new Johns Hopkins research suggests. (Embargo expired on 14-Mar-2011 at 17:00 ET)
Annals of Internal Medicine
—Johns Hopkins Medicine
No comments:
Post a Comment